GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » 1-Year ROIIC %

Sernova Biotherapeutics (FRA:PSH0) 1-Year ROIIC % : -5,625.27% (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Sernova Biotherapeutics's 1-Year ROIIC % for the quarter that ended in Oct. 2024 was -5,625.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Sernova Biotherapeutics's 1-Year ROIIC % or its related term are showing as below:

FRA:PSH0's 1-Year ROIIC % is ranked worse than
98.13% of 1391 companies
in the Biotechnology industry
Industry Median: -9.34 vs FRA:PSH0: -5625.27

Sernova Biotherapeutics 1-Year ROIIC % Historical Data

The historical data trend for Sernova Biotherapeutics's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics 1-Year ROIIC % Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,911.63 -300.00 12,203.42 7,190.87 -5,625.27

Sernova Biotherapeutics Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,190.87 -18,203.90 -14,052.31 4,344.74 -5,625.27

Competitive Comparison of Sernova Biotherapeutics's 1-Year ROIIC %

For the Biotechnology subindustry, Sernova Biotherapeutics's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's 1-Year ROIIC % falls into.



Sernova Biotherapeutics 1-Year ROIIC % Calculation

Sernova Biotherapeutics's 1-Year ROIIC % for the quarter that ended in Oct. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -21.1332258 (Oct. 2024) - -27.972 (Oct. 2023) )/( 0.773 (Oct. 2024) - 0.909 (Oct. 2023) )
=6.8387742/-0.136
=-5,028.51%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Sernova Biotherapeutics  (FRA:PSH0) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Sernova Biotherapeutics 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines